Press Releases

Press Releases

IVI and Sweden renew partnership to accelerate vaccines for global public health

IVI to lead critical standard reagents availability for oral cholera vaccine manufacturing to ensure their uniform efficacy and help meet global demand

IVI appoints three new members to its Board of Trustees

IVI to Accelerate Efforts in iNTS Vaccine Development

IVI acquires GCLP certification from Korean Ministry of Food and Drug Safety

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

IVI Discusses Expanding Support for Global Collaboration on Vaccine R&D and Delivery with Top Foreign Diplomats in Seoul

IVI-led Consortium Awarded Fleming Fund Regional Grant to Improve Data Sharing in Fight against Antimicrobial Resistance

IVI to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in Seoul

IVI acquires supplemental funding for Severe Typhoid in Africa Program (SETA Plus)

IVI Director General Dr. Jerome Kim to join the Human Vaccines Project’s Efforts as One of Four Distinguished Global Leaders to Decode the Human Immune System

Prof. Young Chul Sung, biotech leader, personally donates US$8.4 million to IVI

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

Vaccine study confirms sensitivity of cholera test

Korean Pediatric Association, IVI, KSC exchange MOU

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

Henry Lau joins IVI as Goodwill Ambassador

Nature Communications study addresses MDR typhoid

THSTI, IVI held joint symposium on Nov. 22

‘The Euvichol story’ published in Vaccine

IVI accelerates development of MERS vaccine

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera

IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience


IVI Board of Trustees Meeting and Visit by Sida

2016-10-10 02:25
IVI Board of Trustees Meeting and Visit by Sida

The week of October 12th was a busy one at IVI with a visit by the Swedish International Development Cooperation Agency (Sida) and the annual gathering of the IVI Board of Trustees (BOT).

Ros Mari Balow, the Sida representative who oversees IVI, visited the IVI headquarters from Oct. 14-16 where she met the Dr. Jerome Kim for the first time since he started his term as Director General and the IVI teams, and participated in the BOT meeting. In addition to being an IVI signatory country, Sweden has been a major contributor of core funds to IVI since 2002. The visit reaffirmed the solid partnership between IVI and Sida.

Ros Mari Balow of Sida (third from right) and Viveka Persson, the Swedish representative on the IVI Board (fourth from right), with the IVI team

The BOT meeting took place from Oct. 15-16 at the IVI headquarters and is one of two face-to-face meetings held annually. The meeting is an opportunity for Board members to get institutional updates, and to discuss and make decisions on major issues facing the organization. The major topic at this meeting was IVI’s new strategy and organizational plan to support the strategy. A strategic refresh was initiated since the start of Dr. Kim’s appointment and is currently being supported by the Boston Consulting Group. These organizational changes will make IVI more effective and efficient on delivering in its mission and help ensure the future sustainability of the organization. The new strategic plan will be announced at the end of the year.

IVI Board Members. Front row from left: Dr. Joseph Kim, Prof. Adel Mahmoud (Chair), Dr. Jerome Kim, Dr. Viveka Persson, Prof. Fred Binka; Second row from left: Mr.Young Gon Kim; Dr. George Siber; and Mr. George Bickerstaff

It was also during the meeting that the Korean Ministry of Education (MOE) was acknowledged for its long-standing support of IVI. MOE has been the ministry that presides over IVI on behalf of the Korean government and has been working with IVI since the Institute’s early beginnings in Korea. MOE’s International Cooperation Bureau team received a plaque of appreciation during a special ceremony.

Director General Young Gon Kim of MOE’s International Cooperation Bureau with IVI Board Chair Prof. Adel Mahmoud